October 20, 1998
Memo To: Health, Medical, and Science Journalists
From: Bill Glitz
Subject: Conference For Medical, Health, And Science Journalists On Emerging Medical And Scientific Information On Impotence
Ever since the FDA approval of Viagra this past spring, impotence has received extensive and intensive ongoing coverage in the media. Since that watershed event in March and the reporting of new research data at the American Urological Association Annual Meeting in June, major new developments have occurred regarding the diagnosis and treatment of impotence.
In order to update editors and reporters on new developments and emerging scientific information regarding impotence, the American Foundation for Urologic Disease (AFUD) and NIH's National Institute of Diabetes and Digestive and Kidney Disease have scheduled an update conference for journalists reviewing the latest medical and scientific information on impotence. The conference will take place on the NIH campus in Bethesda on Monday, October 26 beginning at 8 a.m. with registration and a continental breakfast. It will be held in Conference Room 6C10 on the sixth floor of Building 31. The first session will start at 8:30 a.m. and the last presentation is scheduled to end at 3:30 p.m.
Conference participants include several of the leading experts on impotence from United States and several other countries.
Some of the topics to be addressed include:
- the presentation of new research data on how emerging therapies for
erectile dysfunction are impacting on the healthcare system.
- an examination of third party reimbursement issues pertaining to the use
of these new therapies.
- a discussion of the ethical issues associated with the marketing of new
therapies for impotence.
- an update on oral treatments for erectile dysfunction currently under
- an examination of the potential of gene therapy for treating impotence.
- a look at the development of transdermal delivery of impotence
- a review of new advances in diagnosing erectile dysfunction.
If you would like additional information prior to the conference, contact Bill Glitz at (703) 532-3797.